Table 1.
Characteristics of the study cohort at baseline and follow-up
| Variables | Baseline | Follow-up | P value* |
| Age (years) | 46.3 (2.63) | 49.8 (2.69) | <0.001 |
| Smoker, n (%) | 184 (13.3) | 165 (11.9) | 0.303 |
| Drinker, n (%) | 266 (19.2) | 355 (25.6) | <0.001 |
| BMI (kg/m2) | 27.3 (6.68) | 28.1 (6.82) | 0.003 |
| FPG (mmol/L) | 5.09 (0.61) | 5.04 (0.70) | 0.062 |
| Insulin (uIU/mL) | 10.1 (6.91) | 10.9 (7.14) | 0.002 |
| HOMA-IR | 2.36 (1.91) | 2.54 (1.99) | 0.015 |
| TC (mmol/L) | 4.97 (0.82) | 5.20 (0.91) | <0.001 |
| TG (mmol/L) | 1.17 (0.59) | 1.28 (0.67) | <0.001 |
| HDL-C (mmol/L) | 1.51 (0.36) | 1.56 (0.39) | 0.001 |
| LDL-C (mmol/L) | 2.92 (0.76) | 3.05 (0.81) | <0.001 |
| LpA-I (mg/dL) | 49.3 (12.3) | 53.9 (14.9) | <0.001 |
| ApoA-I (mg/dL) | 153.7 (25.3) | 164.2 (27.7) | <0.001 |
| ApoB (mg/dL) | 106.0 (25.7) | 109.9 (27.6) | <0.001 |
The number of subjects, N=1386.
Study variables are presented as mean (SD) or n (%).
*P value for the difference of variables between baseline and follow-up.
ApoA-I, apolipoprotein A-I; ApoB, apolipoprotein B; BMI, body mass index; FPG, fasting plasma glucose; HDL-C, high-density lipoprotein cholesterol; HOMA-IR, homeostasis model assessment of insulin resistance; LDL-C, low-density lipoprotein cholesterol; LpA-I, lipoprotein A-I; TC, total cholesterol; TG, triglyceride.